I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

The FDA gave compounding pharmacies 60 to 90 days ... A few pills have emerged, however: Novo sells a pill form of ...

President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland ...

A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for alternative ways to administer anti-obesity drugs. | Found is offering a cheaper, ...

After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking ...

The UAE has introduced a new law to regulate medical products, pharmacies, and pharmaceutical businesses, aiming to enhance organisation, security, and efficient oversight of development and ...

DUBLIN--(BUSINESS WIRE)--The "U.S. Compounding Pharmacy Market - Industry Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering. The U.S. compounding pharmacies ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version in early 2025 ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version in early 2025 Charlotte Phillipp is a Weekend Writer-Reporter at ...